Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Europe. The aim of this observational study is to observe the efficacy of Levemir® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. Furthermore the time period between diagnosis of type 2 diabetes and insulin initiation is evaluated.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Patients with type 2 diabetes mellitus

• Insulin-naive or currently treated with another basal insulin

• Inclusion of patients at the discretion of the treating physician after the decision to prescribe Levemir®

Exclusion Criteria:

• Type 1 diabetes mellitus

• Patients treated with short acting or with premix insulin

• Women who are pregnant, breast feeding or have the intention to become pregnant

• Known or suspected allergy to the study product or related product

• Any exclusion criteria according to the Swiss Levemir® SPC (Summary of Product Characteristics)